Prevnar

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Chronic Obstructive Pulmonary DiseaseTuberculosisHepatitisJapanese EncephalitisPneumococcal Infection

557 competitors in Chronic Obstructive Pulmonary Disease

#DrugCompanyPhaseTrials

1

Prevnar

GSK

Approved

12

Veramyst

GSK

Preclinical

263

Flovent

GSK

Preclinical

64

Duragesic

CCephalon

Preclinical

25

Narcan

SScienture

Preclinical

16

Coumadin

AAbbott

Preclinical

17

Zoloft

VViatris Specialty LLC

Preclinical

18

Insulin Therapy

Sanofi

Preclinical

19

Versed

CConrado Roberto Hoffmann Filho

Preclinical

—10

Emend

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

—Show 16 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Vaccine5 trials

Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.

Completed·GSK·Phase 3·NCT00345683·4,021 enrolled

Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.

Completed·GSK·Phase 2·NCT00729001·529 enrolled

Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine

Completed·GSK··NCT00146835·120,794 enrolled

Show 2 more trials

Safety and Tolerability Study for the Pneumococcal Conjugate Vaccine V114 Versus Prevnar™ (V114-001)

Completed·Merck & Co.·Phase 1·NCT01215175·150 enrolled

Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine

Completed·GSK·Phase 2·NCT00129129·756 enrolled

Immunogenicity4 trials

Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age

Completed·GSK·Phase 2·NCT00578175·1,851 enrolled

Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With Prevnar

Completed·Sanofi·Phase 3·NCT00594347·339 enrolled

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Completed·GSK·Phase 2·NCT00861744·1,259 enrolled

Show 1 more trial

Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine

Completed·GSK·Phase 3·NCT00289783·4,441 enrolled

Clinical Trial3 trials

Clinical Trial of PCV24 in Infants Aged 2-23 Months

Recruiting·SSinovac Life Sciences Co., Ltd.·Phase 1·NCT06800261·180 enrolled

Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine

Recruiting·SSinovac Life Sciences Co., Ltd.·Phase 3·NCT06617715·3,080 enrolled

Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years

Recruiting·SSinovac Life Sciences Co., Ltd.·Phase 2·NCT07300644·420 enrolled

Vaccination2 trials

Pneumococcal Vaccination of Fiji Infants

Completed·UUniversity of Melbourne·Phase 2·NCT00170612·552 enrolled

Early Versus Delayed Pneumococcal Vaccination in HIV

Completed·CCIHR Canadian HIV Trials Network·Phase 1/2·NCT00137605·79 enrolled

Antibody1 trial

Antibody Production in Immune Disorders

Terminated·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 4·NCT00023504·21 enrolled

10 more indications

Long-term Follow-up1 trial

Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine

Completed·GSK·Phase 2·NCT00323622·1,737 enrolled

Japanese encephalitis1 trial

Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population

Completed·VValneva Austria GmbH·Phase 3·NCT01041573·1,869 enrolled

Pneumococcal Infection1 trial

Humoral Determinants of Immunity to Pneumococcal Infection

Completed·VVA Office of Research and Development·Phase 4·NCT00304382·114 enrolled

Elderly1 trial

Study of Gamma PN3 in the Elderly

Completed·GGPN Vaccines·Phase 1·NCT06562790·105 enrolled

Chronic Obstructive Pulmonary Disease1 trial

Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease

Completed·UUniversity of Minnesota·Phase 3·NCT00457977·181 enrolled

Vaccines1 trial

Does the Order in Which Vaccines Are Administered Affect Pain Response?

Completed·TThe Hospital for Sick Children·Phase 4·NCT00390130·120 enrolled

Tuberculosis1 trial

Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants

Completed·GSK·Phase 2·NCT01098474·301 enrolled

Primary Peritoneal Cancer1 trial

A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Terminated·—·Phase 1/2·NCT01312389·3 enrolled

Hepatitis1 trial

Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age

Completed·GSK·Phase 3·NCT00197002·521 enrolled

Unspecified1 trial

Systems Biology of PNEUMOVAX®23 and PREVNAR 13®

Completed·EEmory University·N/A·NCT01307449·88 enrolled

Details

Drug Info

Related News